{"schema_version":"secwatch.filing_event.v1","accession":"0001447362-22-000203","form_type":"8-K","ticker":"CSTL","cik":"0001447362","company_name":"CASTLE BIOSCIENCES INC","filed_at":"2022-12-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:50.700060+00:00","generated_at":"2026-06-20T22:23:43.350498+00:00","sec_items":["5.02"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Castle Biosciences adopts 2022 Inducement Plan for 350,000 shares to attract new employees","bullets":["Board approved 2022 Inducement Plan reserving 350,000 shares of common stock for new hires as material inducement.","Plan adopted without stockholder approval under Nasdaq Listing Rule 5635(c)(4).","Awards include nonstatutory stock options, SARs, restricted stock, RSUs, and performance-based awards.","Terms substantially similar to the company's stockholder-approved 2019 Equity Incentive Plan."],"urls":{"canonical":"https://secwatch.observer/filing/0001447362-22-000203","json":"https://secwatch.observer/filing/0001447362-22-000203.json","markdown":"https://secwatch.observer/filing/0001447362-22-000203.md","text":"https://secwatch.observer/filing/0001447362-22-000203.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1447362/000144736222000203/0001447362-22-000203-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1447362/000144736222000203/cstl-20221222.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T22:23:43.350498+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}